These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 12209641)

  • 1. MHC class II isotype-specific signaling complex on human B cells.
    Lévéille C; Castaigne JG; Charron D; Al-Daccak R
    Eur J Immunol; 2002 Aug; 32(8):2282-91. PubMed ID: 12209641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHC class II molecules deliver costimulatory signals in human T cells through a functional linkage with IL-2-receptors.
    Odum N; Kanner SB; Ledbetter JA; Svejgaard A
    J Immunol; 1993 Jun; 150(12):5289-98. PubMed ID: 8515060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC class II molecules activate NFAT and the ERK group of MAPK through distinct signaling pathways in B cells.
    Haylett RS; Koch N; Rink L
    Eur J Immunol; 2009 Jul; 39(7):1947-55. PubMed ID: 19544309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY.
    Szöllósi J; Horejsí V; Bene L; Angelisová P; Damjanovich S
    J Immunol; 1996 Oct; 157(7):2939-46. PubMed ID: 8816400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early biochemical events after MHC class II-mediated signaling on human B lymphocytes.
    Mooney NA; Grillot-Courvalin C; Hivroz C; Ju LY; Charron D
    J Immunol; 1990 Oct; 145(7):2070-6. PubMed ID: 2398273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The context of HLA-DR/CD18 complex in the plasma membrane governs HLA-DR-derived signals in activated monocytes.
    Doisne JM; Castaigne JG; Deruyffelaere C; Dieu-Nosjean MC; Chamot C; Alcaide-Loridan C; Charron D; Al-Daccak R
    Mol Immunol; 2008 Feb; 45(3):709-18. PubMed ID: 17719638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of tyrosine phosphorylation in human MHC class II-positive antigen-presenting cells by stimulation with contact sensitizers.
    Kühn U; Brand P; Willemsen J; Jonuleit H; Enk AH; van Brandwijk-Petershans R; Saloga J; Knop J; Becker D
    J Immunol; 1998 Jan; 160(2):667-73. PubMed ID: 9551901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling through HLA-DR induces PKC beta-dependent B cell death outside rafts.
    Guo W; Castaigne JG; Mooney N; Charron D; Al-Daccak R
    Eur J Immunol; 2003 Apr; 33(4):928-38. PubMed ID: 12672059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conserved residues of the bare lymphocyte syndrome transcription factor RFXAP determine coordinate MHC class II expression.
    Long AB; Ferguson AM; Majumder P; Nagarajan UM; Boss JM
    Mol Immunol; 2006 Feb; 43(5):395-409. PubMed ID: 16337482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel HLA class II molecule (DR alpha-DQ beta) created by mismatched isotype pairing.
    Lotteau V; Teyton L; Burroughs D; Charron D
    Nature; 1987 Sep 24-30; 329(6137):339-41. PubMed ID: 3306409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal adhesion kinase mediates human leukocyte histocompatibility antigen class II-induced signaling in gingival fibroblasts.
    Yoshizawa S; Meguro M; Ohyama H; Takeuchi-Hatanaka K; Matsushita S; Takashiba S; Nishimura F
    J Periodontal Res; 2007 Dec; 42(6):572-9. PubMed ID: 17956472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TAPA-1 molecule is associated on the surface of B cells with HLA-DR molecules.
    Schick MR; Levy S
    J Immunol; 1993 Oct; 151(8):4090-7. PubMed ID: 8409388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of HLA-DR molecules transduces agonistic functional signals in cutaneous melanoma.
    Altomonte M; Visintin A; Tecce R; Leonardi A; Calabro L; Fonsatti E; Pucillo C; Maio M
    J Cell Physiol; 2004 Aug; 200(2):272-6. PubMed ID: 15174097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-linking of MHC class II molecules interferes with phorbol 12,13-dibutyrate-induced differentiation of resting B cells by inhibiting Rac-associated ROS-dependent ERK/p38 MAP kinase pathways leading to NF-kappaB activation.
    Yang HY; Kim J; Chung GH; Lee JC; Jang YS
    Mol Immunol; 2007 Mar; 44(7):1577-86. PubMed ID: 17011624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-linking of insulin receptors to MHC antigens in human B lymphocytes: evidence for selective molecular interactions.
    Samson M; Cousin JL; Fehlmann M
    J Immunol; 1986 Oct; 137(7):2293-8. PubMed ID: 3531328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-adhesive signals are mediated via major histocompatibility complex class II molecules in normal and neoplastic human B cells: correlation with B cell differentiation stage.
    Ahsmann EJ; Boom SE; Lokhorst HM; Rijksen G; Bloem AC
    Eur J Immunol; 1997 Oct; 27(10):2688-95. PubMed ID: 9368627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.
    Rodríguez T; Méndez R; Del Campo A; Jiménez P; Aptsiauri N; Garrido F; Ruiz-Cabello F
    BMC Cancer; 2007 Feb; 7():34. PubMed ID: 17319941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DR signaling inhibits Fas-mediated apoptosis in A375 melanoma cells.
    Aoudjit F; Guo W; Gagnon-Houde JV; Castaigne JG; Alcaide-Loridan C; Charron D; Al-Daccak R
    Exp Cell Res; 2004 Sep; 299(1):79-90. PubMed ID: 15302575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class II signaling function is regulated during maturation of plasmacytoid dendritic cells.
    Drénou B; Amiot L; Setterblad N; Taque S; Guilloux V; Charron D; Fauchet R; Mooney N
    J Leukoc Biol; 2005 Apr; 77(4):560-7. PubMed ID: 15647325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis.
    Martins I; Sylla K; Deshayes F; Lauriol J; Ghislin S; Dieu-Nosjean MC; Viguier M; Verola O; Charron D; Alcaide-Loridan C; Al-Daccak R
    Melanoma Res; 2009 Aug; 19(4):226-37. PubMed ID: 19574933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.